Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 331 of 1,261
  1. US 11053285

    Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use

    The Government of the United States, as represented by the Secretary of the Army · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  2. US 11053280

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  3. US 11053286

    Stabilised FMDV capsids

    The Pirbright Institute · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  4. US 11053261

    Solid state forms of ixazomib citrate

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  5. US 11053213

    Pharmaceutical compounds

    ALMAC DISCOVERY LIMITED · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  6. US 11053242

    [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  7. US 11052118

    Enhanced stem cell composition

    Fate Therapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  8. US 11052157

    Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  9. US 11052123

    Method of obtaining olive oil and extracts from olives

    Isanatur Spain S.L. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  10. US 11052116

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  11. US 11052115

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  12. US 11052089

    Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype

    The Regents of the University of California · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  13. US 11052103

    Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  14. US 11053294

    Masked cytokine polypeptides

    Xilio Development, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  15. US 11052060

    Compounds and methods for treating autoimmunity

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  16. US 11052044

    In situ lipid synthesis for protein reconstitution

    The Regents of the University of California · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  17. US 11052029

    Cation compatible metal oxides and oral care compositions containing the metal oxides

    W.R. Grace & Co.-Conn. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  18. US 11052066

    Ultrapure tetrahydrocannabinol-11-oic acids

    Corbus Pharmaceuticals, Inc. · Granted Jul 6, 2021 · Expires Jul 1, 2041

    granted
  19. US 11045457

    Piperidinyl-3-(aryloxy)propanamides and propanoates

    Takeda Pharmaceutical Company Limited · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  20. US 11045461

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  21. US 11045443

    Glutaminase inhibitor therapy

    The Board of Regents of the University of Texas System · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  22. US 11046759

    Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  23. US 11046946

    PEGylated L-asparaginase

    Jazz Pharmaceuticals II SAS · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  24. US 11045448

    Piperidines as covalent menin inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.